Phase 1 Metastatic Nasopharyngeal Carcinoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Recurrent or Metastatic Nasopharyngeal Carcinoma

MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979

Recruiting

Phase 1Phase 2

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Nasopharyngeal Cancinoma (NPC)Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharynx Carcinoma

Sun Yat-Sen University Cancer Center148 enrolled1 locationNCT06802835

Recruiting

Phase 1

Metastatic Nasopharyngeal Carcinoma

Chen Xiaozhong47 enrolled1 locationNCT06886347